PE20070432A1 - Dispositivos de administracion transdermicas de farmacos que contienen o-desmetilvenlafaxina (odv) o sus sales - Google Patents
Dispositivos de administracion transdermicas de farmacos que contienen o-desmetilvenlafaxina (odv) o sus salesInfo
- Publication number
- PE20070432A1 PE20070432A1 PE2006001080A PE2006001080A PE20070432A1 PE 20070432 A1 PE20070432 A1 PE 20070432A1 PE 2006001080 A PE2006001080 A PE 2006001080A PE 2006001080 A PE2006001080 A PE 2006001080A PE 20070432 A1 PE20070432 A1 PE 20070432A1
- Authority
- PE
- Peru
- Prior art keywords
- transdermal administration
- patch
- desmetilvenlafaxine
- odv
- salts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
Abstract
SE REFIERE A UN DISPOSITIVO DE ADMINISTRACION TRANSDERMICA TAL COMO PARCHE, QUE COMPRENDE a) UN CANTIDAD TERAPEUTICAMENTE EFECTIVA DE O-DESMETILVENLAFAXINA (0DV) ENTRE 5 A 500 MG APROXIMADAMENTE; b) UN POTENCIADOR DE ABSORCION SELECCIONADO DE PENTADECALACTONA, 1,3-DIOXALANOS, ENTRE OTROS; c) UN VEHICULO O EXCIPIENTE SELECCIONADO DE TROMETANETANOL, POLIETILENGLICOL, GLICERINA, ENTRE OTROS; Y d) ADEMAS PUEDE COMPRENDER AL MENOS OTRO AGENTE TERAPEUTICO SELECCIONADO DE ANALGESICO, ANESTESICO, MIORRELAJANTES, ENTRE OTROS. ESTE PARCHE TRANSDERMICO ES UN PARCHE DE DEPOSITO, DE MATRIZ O UN PARCHE DE FARMACO ADHESIVO Y OPTATIVAMENTE COMPRENDE UNA CUBIERTA DESPRENDIBLE. ES UTIL EN EL TRATAMIENTO DE TRASTORNOS DEPRESIVOS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71458205P | 2005-09-07 | 2005-09-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20070432A1 true PE20070432A1 (es) | 2007-04-26 |
Family
ID=37836371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006001080A PE20070432A1 (es) | 2005-09-07 | 2006-09-07 | Dispositivos de administracion transdermicas de farmacos que contienen o-desmetilvenlafaxina (odv) o sus sales |
Country Status (18)
Country | Link |
---|---|
US (1) | US20070053968A1 (es) |
EP (1) | EP1924249A2 (es) |
JP (1) | JP2009507076A (es) |
KR (1) | KR20080041240A (es) |
CN (1) | CN101304734A (es) |
AR (1) | AR055628A1 (es) |
AU (1) | AU2006287652A1 (es) |
BR (1) | BRPI0617168A2 (es) |
CA (1) | CA2620160A1 (es) |
CR (1) | CR9737A (es) |
EC (1) | ECSP088252A (es) |
GT (1) | GT200600396A (es) |
IL (2) | IL184496A0 (es) |
NO (1) | NO20080936L (es) |
PE (1) | PE20070432A1 (es) |
RU (1) | RU2008106935A (es) |
TW (1) | TW200744678A (es) |
WO (1) | WO2007030434A2 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009155488A2 (en) * | 2008-06-19 | 2009-12-23 | Segrub, Llc | Novel oxalate salt and crystal of o-desmethylvenlafaxine |
WO2010019953A1 (en) | 2008-08-15 | 2010-02-18 | Arcion Therapeutics, Inc. | High concentration local anesthetic formulations for treating non-neuropathic pain |
CZ301820B6 (cs) * | 2009-02-06 | 2010-06-30 | Zentiva, K.S. | Nové soli desvenlafaxinu a zpusob jejich prípravy |
JP5900971B2 (ja) * | 2011-02-02 | 2016-04-06 | 大日本住友製薬株式会社 | 経皮吸収促進剤及びそれを含有する経皮吸収型製剤 |
US20140056965A1 (en) * | 2012-08-24 | 2014-02-27 | Boston Scientific Neuromodulation Corporation | Method and system for treating depression or epilepsy |
US9072682B2 (en) | 2012-12-31 | 2015-07-07 | Mylan Inc. | Transdermal dosage form for low-melting point active agent |
EP2946775A1 (de) * | 2014-05-20 | 2015-11-25 | LTS LOHMANN Therapie-Systeme AG | Lavendelöl enthaltendes transdermales therapeutisches System |
CN106692118A (zh) * | 2016-11-18 | 2017-05-24 | 广州军区广州总医院 | 文拉法辛在制备预防或治疗轻型脑损伤后认知功能障碍的药物中的应用 |
EP3691649B1 (en) * | 2017-10-06 | 2022-10-12 | Eluciderm Inc. | Compositions and methods for wound treatment |
KR20200070305A (ko) * | 2017-10-11 | 2020-06-17 | 에르테에스 로만 테라피-시스테메 아게 | 실리콘 폴리머를 포함하는 구안파신의 경피 투여용 경피흡수 치료 시스템 |
WO2019089942A1 (en) * | 2017-11-02 | 2019-05-09 | Rick Coulon | Formulations for use in the transdermal delivery of proteasome inhibitors |
AU2020375825A1 (en) * | 2019-11-01 | 2022-06-02 | Dechra Veterinary Products, Llc | Therapeutic formulations and uses thereof |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4336243A (en) * | 1980-08-11 | 1982-06-22 | G. D. Searle & Co. | Transdermal nitroglycerin pad |
US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
US4761501A (en) * | 1983-10-26 | 1988-08-02 | American Home Products Corporation | Substituted phenylacetamides |
US4751087A (en) * | 1985-04-19 | 1988-06-14 | Riker Laboratories, Inc. | Transdermal nitroglycerin delivery system |
US4615699A (en) * | 1985-05-03 | 1986-10-07 | Alza Corporation | Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes |
US4861764A (en) * | 1986-11-17 | 1989-08-29 | Macro Chem. Corp. | Percutaneous absorption enhancers, compositions containing same and method of use |
US6572880B2 (en) * | 1996-10-24 | 2003-06-03 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
DK1466889T3 (da) * | 1999-04-06 | 2008-09-08 | Sepracor Inc | O-Desmethylvenlafaxin-succinat |
DE10042412B4 (de) * | 2000-08-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung |
ATE369330T1 (de) * | 2001-02-12 | 2007-08-15 | Wyeth Corp | O-desmethyl-venlafaxine succinat salz |
JP4445853B2 (ja) * | 2002-06-10 | 2010-04-07 | ワイス エルエルシー | 新規o−デスメチルベンラファクシンギ酸塩 |
US7345096B2 (en) * | 2002-10-15 | 2008-03-18 | Wyeth | Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
WO2006084082A1 (en) * | 2005-02-03 | 2006-08-10 | Duramed Pharmaceuticals, Inc. | Compositions of unconjugated estrogens and methods for their use |
-
2006
- 2006-08-31 GT GT200600396A patent/GT200600396A/es unknown
- 2006-09-05 US US11/515,708 patent/US20070053968A1/en not_active Abandoned
- 2006-09-05 AR ARP060103864A patent/AR055628A1/es unknown
- 2006-09-06 TW TW095132871A patent/TW200744678A/zh unknown
- 2006-09-06 BR BRPI0617168-0A patent/BRPI0617168A2/pt not_active Application Discontinuation
- 2006-09-06 CN CNA2006800414208A patent/CN101304734A/zh active Pending
- 2006-09-06 AU AU2006287652A patent/AU2006287652A1/en not_active Abandoned
- 2006-09-06 JP JP2008530132A patent/JP2009507076A/ja active Pending
- 2006-09-06 KR KR1020087005763A patent/KR20080041240A/ko not_active Application Discontinuation
- 2006-09-06 CA CA002620160A patent/CA2620160A1/en not_active Abandoned
- 2006-09-06 EP EP06802938A patent/EP1924249A2/en not_active Withdrawn
- 2006-09-06 WO PCT/US2006/034505 patent/WO2007030434A2/en active Application Filing
- 2006-09-06 RU RU2008106935/15A patent/RU2008106935A/ru not_active Application Discontinuation
- 2006-09-07 PE PE2006001080A patent/PE20070432A1/es not_active Application Discontinuation
-
2007
- 2007-07-09 IL IL184496A patent/IL184496A0/en unknown
-
2008
- 2008-02-13 IL IL189496A patent/IL189496A0/en unknown
- 2008-02-15 CR CR9737A patent/CR9737A/es not_active Application Discontinuation
- 2008-02-25 NO NO20080936A patent/NO20080936L/no not_active Application Discontinuation
- 2008-03-07 EC EC2008008252A patent/ECSP088252A/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL184496A0 (en) | 2007-10-31 |
CA2620160A1 (en) | 2007-03-15 |
EP1924249A2 (en) | 2008-05-28 |
CN101304734A (zh) | 2008-11-12 |
NO20080936L (no) | 2008-06-03 |
WO2007030434A3 (en) | 2007-09-27 |
WO2007030434A2 (en) | 2007-03-15 |
AU2006287652A1 (en) | 2007-03-15 |
TW200744678A (en) | 2007-12-16 |
JP2009507076A (ja) | 2009-02-19 |
BRPI0617168A2 (pt) | 2011-07-12 |
AR055628A1 (es) | 2007-08-29 |
CR9737A (es) | 2008-05-21 |
US20070053968A1 (en) | 2007-03-08 |
ECSP088252A (es) | 2008-04-28 |
RU2008106935A (ru) | 2009-10-20 |
IL189496A0 (en) | 2008-08-07 |
GT200600396A (es) | 2007-04-23 |
KR20080041240A (ko) | 2008-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20070432A1 (es) | Dispositivos de administracion transdermicas de farmacos que contienen o-desmetilvenlafaxina (odv) o sus sales | |
BRPI0719115B8 (pt) | sistema terapêutico transdérmico para administração de buprenorfina à pele | |
CY1120283T1 (el) | Διαδερμικο θεραπευτικο συστημα για την χορηγηση ριβαστιγμινης ή παραγωγων αυτης | |
ECSP056076A (es) | Sistema de suministro para droga y terapia celular | |
GT200500098A (es) | Nuevos compuestos | |
UY30158A1 (es) | Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor | |
AR048336A1 (es) | Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
EA200900155A1 (ru) | Модуляторы фармакокинетических свойств лекарственных средств | |
WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
AR047112A1 (es) | Composiciones de adn estabilizado para recubrir microproyecciones | |
AR051099A1 (es) | Combinaciones terapeuticas que comprenden inhibidor de poli(adp-ribosa)polimerasas | |
MX2012002727A (es) | Sistema terapeutico transdermico para administrar fentanilo o un analogo del mismo. | |
IN2014DN09817A (es) | ||
CO2020000240A2 (es) | Combinación que comprende palbociclib y ácido 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxílico | |
AR044775A1 (es) | Composiciones farmaceuticas de atorvastatina | |
CY1113575T1 (el) | Χρηση συνθεσεων οπιοειδων σε συσκευες χορηγησης δραστικης ουσιας χωρις βελονα | |
PE20070430A1 (es) | Composiciones topicas que comprenden o-desmetilvenlafaxina (odv) | |
PE20061167A1 (es) | Composicion farmaceutica que comprende moduladores de fosfodiesterasa pde4 | |
WO2006091719A3 (en) | Compositions and methods enhancing transdermal delivery of drugs and biologics | |
BR112012014107B8 (pt) | sistema terapêutico transdérmico (tts) e processo de produção de tts | |
AR028525A1 (es) | Sistema terapeutico transdermal para la administracion de lerisetron | |
AR056369A1 (es) | Compuestos derivados de quinazolina y composicion farmaceutica | |
BR112021019190A2 (pt) | Sistema terapêutico transdérmico | |
CA2519789A1 (en) | Aplidine for multiple myeloma treatment | |
UA83036C2 (ru) | Фармацевтическая композиция в виде гидрогеля для трансдермального введения в организм действующих веществ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |